BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37572156)

  • 1. Histological response to radiotherapy is an early event in myxoid liposarcoma.
    Lam SW; Silva TM; Traast-Kooistra J; Bruijn IB; van den Akker B; Bakker PAC; Lansu J; Haas RLM; Bovée JVMG
    Virchows Arch; 2023 Oct; 483(4):487-495. PubMed ID: 37572156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A moderate dose of preoperative radiotherapy may improve resectability in myxoid liposarcoma.
    Lansu J; Braam PM; van Werkhoven E; Scholten AN; Schrage Y; van Houdt WJ; van Langevelde K; Haas RL
    Eur J Surg Oncol; 2021 Oct; 47(10):2633-2639. PubMed ID: 34233858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial.
    Lansu J; Bovée JVMG; Braam P; van Boven H; Flucke U; Bonenkamp JJ; Miah AB; Zaidi SH; Thway K; Bruland ØS; Baldini EH; Jebsen NL; Scholten AN; van den Ende PLA; Krol ADG; Ubbels JF; van der Hage JA; van Werkhoven E; Klomp HM; van der Graaf WTA; van Coevorden F; Schrage Y; van Houdt WJ; Haas RL
    JAMA Oncol; 2021 Jan; 7(1):e205865. PubMed ID: 33180100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant radiotherapy for myxoid liposarcomas: Oncologic outcomes and histopathologic correlations.
    Salduz A; Alpan B; Valiyev N; Özmen E; İribaş A; Ağaoğlu F; Bayram A; Bilgiç B; Özger H
    Acta Orthop Traumatol Turc; 2017 Oct; 51(5):355-361. PubMed ID: 28869066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of neoadjuvant hypofractionated radiotherapy in patients with locally advanced myxoid liposarcoma.
    Koseła-Paterczyk H; Szumera-Ciećkiewicz A; Szacht M; Haas R; Morysiński T; Dziewirski W; Prochorec-Sobieszek M; Rutkowski P
    Eur J Surg Oncol; 2016 Jun; 42(6):891-8. PubMed ID: 27026512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant radiation in primary extremity liposarcoma: correlation of MRI features with histopathology.
    Wortman JR; Tirumani SH; Tirumani H; Shinagare AB; Jagannathan JP; Hornick JL; Ramaiya NH
    Eur Radiol; 2016 May; 26(5):1226-34. PubMed ID: 26314480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermuscular extremity myxoid liposarcoma can be managed by marginal resection following neoadjuvant radiotherapy.
    Perera JR; AlFaraidy M; Ibe I; Aoude A; Acem I; van de Sande MAJ; Dessureault M; Turcotte RE; Mottard S; Basile G; Isler M; Saint-Yves H; Eastley N; Stevenson J; Houdek MT; Chung PWM; Griffin AM; Ferguson P; Wunder JS; Tsoi KM
    Eur J Surg Oncol; 2023 Feb; 49(2):362-367. PubMed ID: 36243649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful salvage treatment of myxoid liposarcoma with multiple peritoneal seeding using helical tomotherapy-based intraperitoneal radiotherapy: a case report.
    Choi C; Park JH; Lee CG; Kim HJ; Suh CO; Cho J
    BMC Res Notes; 2015 May; 8():179. PubMed ID: 25930065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular pattern.
    de Vreeze RS; de Jong D; Haas RL; Stewart F; van Coevorden F
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1480-7. PubMed ID: 18448271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy.
    Wang WL; Katz D; Araujo DM; Ravi V; Ludwig JA; Trent JC; Patel SR; Lin PP; Guadagnolo A; Lòpez-Terrada D; Dei Tos AP; Lewis VO; Lev D; Pollock RE; Zagars GK; Benjamin RS; Madewell JE; Lazar AJ
    Clin Sarcoma Res; 2012 Dec; 2(1):25. PubMed ID: 23272660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of radiotherapy on fat content and fatty acids in myxoid liposarcomas quantified by MRI.
    Skorpil M; Rydén H; Wejde J; Lidbrink E; Brosjö O; Berglund J
    Magn Reson Imaging; 2017 Nov; 43():37-41. PubMed ID: 28698004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation response: an additional unique signature of myxoid liposarcoma.
    Pitson G; Robinson P; Wilke D; Kandel RA; White L; Griffin AM; Bell RS; Catton CN; Wunder JS; O'Sullivan B
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):522-6. PubMed ID: 15380587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas.
    Lansu J; van Houdt WJ; van Langevelde K; van den Ende PLA; van der Graaf WTA; Schrage Y; van Boven H; Scholten AN; Haas RL
    Radiother Oncol; 2021 May; 158():33-39. PubMed ID: 33610624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology.
    Engström K; Bergh P; Cederlund CG; Hultborn R; Willen H; Aman P; Kindblom LG; Meis-Kindblom JM
    Acta Oncol; 2007; 46(6):838-45. PubMed ID: 17653909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.
    Chung PW; Deheshi BM; Ferguson PC; Wunder JS; Griffin AM; Catton CN; Bell RS; White LM; Kandel RA; O'Sullivan B
    Cancer; 2009 Jul; 115(14):3254-61. PubMed ID: 19472403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of myxoid liposarcoma by marginal or intralesional resection combined with radiotherapy.
    Hatano H; Ogose A; Hotta T; Kawashima H; Sugita T; Sasamoto R; Endo N
    Anticancer Res; 2003; 23(3C):3045-9. PubMed ID: 12926159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myxoid\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases.
    Moreau LC; Turcotte R; Ferguson P; Wunder J; Clarkson P; Masri B; Isler M; Dion N; Werier J; Ghert M; Deheshi B;
    Ann Surg Oncol; 2012 Apr; 19(4):1081-8. PubMed ID: 22052112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp90 inhibition by AUY922 as an effective treatment strategy against myxoid liposarcoma.
    Steinmann S; Gali-Muhtasib H; Huebner K; Al-Halabi R; Abou Merhi R; Aman P; Agaimy A; Haller F; Schneider-Stock R
    Cancer Lett; 2015 Oct; 367(2):147-56. PubMed ID: 26225840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Descriptive analysis of MRI functional changes occurring during reduced dose radiotherapy for myxoid liposarcomas.
    Kousi E; Messiou C; Miah A; Orton M; Haas R; Thway K; Hopkinson G; Zaidi S; Smith M; Barquin E; Moskovic E; Fotiadis N; Strauss D; Hayes A; Schmidt MA
    Br J Radiol; 2021 Oct; 94(1126):20210310. PubMed ID: 34545764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon ion radiotherapy for recurrent calf myxoid liposarcoma: a case report.
    Li X; Zhang Y; Ye Y; Qi Y; Feng C; Zhang Y; Hu T; Chen W; Pan X; Chai H
    J Int Med Res; 2021 Apr; 49(4):3000605211009701. PubMed ID: 33884917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.